Class 044: Providing information and providing a website featuring information in the field of hearing loss and the diagnosis and treatment thereof; health care services, namely, providing an online searchable database featuring information regarding hearing loss; providing a database in the field of hearing loss information and featuring inputting and collection of data and information all for tracking the long term impact of genetics and how hearing loss changes over time for treatment and diagnostic purposes
Class 035: Collection and compilation of information into computer databases in the field of hearing loss; maintaining a registry of patient data in the field of hearing loss
Collection and compilation of information into computer databases in the field of hearing loss; maintaining a registry of patient data in the field of hearing loss; Providing information and providing a website featuring information in the field of hearing loss and the diagnosis and treatment thereof; health care services, namely, providing an online searchable database featuring information regarding hearing loss; providing a database in the field of hearing loss information and featuring inputting and collection of data and information all for tracking the long term impact of genetics and how hearing loss changes over time for treatment and diagnostic purposes; Medical and scientific research in the field of hearing loss; maintenance of on-line databases for others in the field of hearing loss
Collection and compilation of information into computer databases in the field of hearing loss; maintaining a registry of patient data in the field of hearing loss; Providing information and providing a website featuring information in the field of hearing loss and the diagnosis and treatment thereof; health care services, namely, providing an online searchable database featuring information regarding hearing loss; providing a database in the field of hearing loss information and featuring inputting and collection of data and information all for tracking the long term impact of genetics and how hearing loss changes over time for treatment and diagnostic purposes; "REGISTRY"; Medical and scientific research in the field of hearing loss; maintenance of on-line databases for others in the field of hearing loss
Genetic testing for medical purposes; genetic counseling; providing a website featuring health and medical information regarding genetic testing and genetic counseling for individuals with a clinical diagnosis of auditory neuropathy; charitable services, namely, providing free genetic testing for medical purposes and genetic counseling to individuals with a clinical diagnosis of auditory neuropathy
Genetic testing for medical purposes; genetic counseling; providing a website featuring health and medical information regarding genetic testing and genetic counseling for individuals with a clinical diagnosis of auditory neuropathy; charitable services, namely, providing free genetic testing for medical purposes and genetic counseling to individuals with a clinical diagnosis of auditory neuropathy
Genetic testing for medical purposes; genetic counseling; providing a website featuring health and medical information regarding genetic testing and genetic counseling for individuals with a clinical diagnosis of auditory neuropathy; charitable services, namely, providing free genetic testing for medical purposes and genetic counseling to individuals with a clinical diagnosis of auditory neuropathy
Scientific research consulting in the field of inner ear disorders and conditions and other causes of hearing loss; custom development of biochemical reagents and biological nanoparticles for therapeutic use featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles for therapeutic use featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restore, improve and preserve hearing, namely, genetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy products, namely, biological preparations for the treatment of inner ear disorders and conditions; viral vectors, non-viral vectors and gene therapy vectors all for medical purposes, namely, therapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human body, for use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restore, improve and preserve hearing, namely, genetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy products, namely, biological preparations for the treatment of inner ear disorders and conditions; viral vectors, non-viral vectors and gene therapy vectors all for medical purposes, namely, therapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human body, for use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
Drug delivery systems comprised of infusion and injection devices for administering drugs; medical devices for use in treating genetically-related inner ear diseases and conditions causing hearing loss
Drug delivery systems comprised of infusion and injection devices for administering drugs; medical devices for use in treating genetically-related inner ear diseases and conditions causing hearing loss
Scientific research consulting in the field of inner ear disorders and conditions and other causes of hearing loss; custom development of biochemical reagents and biological nanoparticles for therapeutic use featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles for therapeutic use featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
